US FDA accepts MS drug Lemtrada resubmission for review
US FDA accepts MS drug Lemtrada resubmission for review
The US Food and Drug Administration (FDA) has accepted for review the Genzyme's resubmission of supplemental Biologics License Application (sBLA) seeking approval of Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis. A six-month review period has been assigned for the Lemtrada sBLA. Genzyme expects FDA action on the sBLA in the fourth quarter...... Read More - http://www.ms-uk.org/lemtrada
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1868 Views
-
Last post by frodo
-
- 0 Replies
- 1211 Views
-
Last post by NHE
-
- 0 Replies
- 1677 Views
-
Last post by frodo
-
- 0 Replies
- 1222 Views
-
Last post by frodo
-
- 1 Replies
- 1705 Views
-
Last post by frodo
-
- 0 Replies
- 1989 Views
-
Last post by NHE
-
- 0 Replies
- 2298 Views
-
Last post by NHE
-
- 0 Replies
- 1063 Views
-
Last post by frodo
-
- 1 Replies
- 1410 Views
-
Last post by NHE